CAS: 189264-04-8 - (2R,4S)-1-[(2S)-5-[(Aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid
Fórmula:C23H36N6O5S
InChI:InChI=1S/C23H36N6O5S/c1-14-8-10-29(18(12-14)22(31)32)21(30)17(6-4-9-26-23(24)25)28-35(33,34)19-7-3-5-16-11-15(2)13-27-20(16)19/h3,5,7,14-15,17-18,27-28H,4,6,8-13H2,1-2H3,(H,31,32)(H4,24,25,26)/t14-,15?,17-,18+/m0/s1
Chave InChI:InChIKey=KXNPVXPOPUZYGB-UNPWZGGWSA-N
SMILES:O=C(O)C1N(C(=O)C(NS(=O)(=O)C=2C=CC=C3C2NCC(C)C3)CCCNC(=N)N)CCC(C)C1
- Sinónimos:
- (2R,4S)-1-[(2S)-5-[(Aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid
- 2-Piperidinecarboxylic acid, 1-[5-[(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-, [2R-[1(2S*),2α,4α]]-[partial]-
- 2-Piperidinecarboxylic acid, 1-[(2S)-5-[(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-, (2R,4S)-
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
Argatroban (L,2R,4S)-Isomer (Mixture of Diastereomers) REF: 4Z-A-5910CAS: 189264-04-8 | - - - | A consultar | Ter 10 Dez 24 | |
(2R, 4S)-1-(2S)-Argatroban REF: TR-A189265CAS: 189264-04-8 | - - - | 284,00 €~1.973,00 € | Qua 18 Dez 24 | |
(2R, 4S)-1-(2S)- Argatroban REF: 3D-PHA26404CAS: 189264-04-8 | Min. 95% | - - - | Produto descontinuado |
Argatroban (L,2R,4S)-Isomer (Mixture of Diastereomers)
Ref: 4Z-A-5910
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
(2R, 4S)-1-(2S)-Argatroban
Produto ControladoRef: TR-A189265
1mg | 284,00 € | ||
5mg | 1.216,00 € | ||
10mg | 1.973,00 € |
(2R, 4S)-1-(2S)- Argatroban
Ref: 3D-PHA26404
1mg | Descontinuado | Solicitar informações | |
5mg | Descontinuado | Solicitar informações | |
10mg | Descontinuado | Solicitar informações | |
25mg | Descontinuado | Solicitar informações | |
50mg | Descontinuado | Solicitar informações |